AMCP Annual Meeting 2017

Industry Workshops


TUESDAY, MARCH 28
11:25 am - 12:25 pm
Mile High 4A-4C
Amgen, Inc.

11:25 am - 12:25 pm
Mile High 1A-1C
Biogen

7:30 pm – 8:30 pm
Mile High 4A-4C
Intarcia
Longitudinal Assessment of Clinical and Economic Outcomes of Type 2 Diabetes: An Actuarial Analysis

7:30 pm – 8:30 pm
Mile High 1A-1C
Novo Nordisk
More Than A1C

A panel discussion with 4 KOLs that will be conducted by a recruited moderator on Tuesday, March 28. There will be a presentation and moderator's guide developed to assist the flow of the workshop. Some key message points include T2D patients who often suffer from many other comorbidities (either caused by, or that cause diabetes), and how these comorbidities can be costly for a population. Cardiovascular events are some of the most costly, and include stroke, heart failure, and even death. Will focus on the prevalence in T2D vs normal population, and will detail the average cost.


© 2017 Academy of Managed Care Pharmacy | 675 North Washington Street, Suite 220, Alexandria, VA 22314 | 703-684-2600 | webmaster@amcp.org